Zobowiązania Handlowe Zmiana Data
AbbVie USD 33.3B 29.71B 2026-06
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
Agios Pharmaceuticals USD 19.93M 3.58M 2026-09
Alnylam Pharmaceuticals USD 135.4M 27.38M 2026-09
Amgen USD 20.83B 17.97B 2026-09
Arrowhead Research USD 30.15M 2.37M 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Gilead Sciences USD 934M 260M 2026-09
Incyte USD 235.37M 1.16B 2026-09
Insmed USD 84.3M 9.75M 2026-09
Ionis Pharmaceuticals USD 27.11M 20.59M 2026-09
J&J USD 9.32B 94M 2026-09
Merck USD 5.03B 1.2B 2026-09
Moderna USD 259M 92M 2026-09
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novartis USD 4.24B 15M 2026-09
Pfizer USD 4.07B 511M 2026-09
PTC Therapeutics USD 41.59M 1.14M 2026-09
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 24.55B 957M 2026-09
Sarepta Therapeutics USD 45.7M 5.28M 2026-09
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
United Therapeutics USD 520.2M 22.4M 2026-09
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09